← Eichor
Condition: Cirrhosis Of Liver Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cirrhosis Of Liver

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Phase 2 · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06599918Functional Assessment in Liver Transplantation
Phase N/A · 12 location(s) · University of California, San Francisco · NCT03228290Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NA · 1 location(s) · Air Force Military Medical University, China · NCT07253389The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
NA · 1 location(s) · Northern Jiangsu People's Hospital · NCT05325424A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Phase 3 · 1 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT07343778A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholang
Phase N/A · 68 location(s) · Ipsen · NCT06447168Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Phase 4 · 6 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04073290Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NA · 1 location(s) · Henry Ford Health System · NCT06269510Periinterventional Coagulation Management of Patients Undergoing a TIPS
NA · 1 location(s) · Medical University of Graz · NCT04421924Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NA · 2 location(s) · Nantes University Hospital · NCT06735560LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
NA · 1 location(s) · Massachusetts General Hospital · NCT05998330Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Phase N/A · 1 location(s) · Chongqing Medical University · NCT05974904Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhos
Phase 2 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06526104Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
NA · 2 location(s) · Kalliopi Anna Poulia · NCT07561138LEOPARD Training and Validation Data Collection Study
Phase N/A · 53 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06675604Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis
Phase 3 · 8 location(s) · Consorcio Centro de Investigación Biomédica en Red (CIBER) · NCT06533852A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 317 location(s) · 89bio, Inc. · NCT06419374A Study of SIPLIZUMAB in AILD and LT Patients
Phase 1 · 1 location(s) · Elizabeth C. Verna · NCT06455280Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontan
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06026267Hepatic and Systemic Hemodynamic Modeling During Liver Surgery
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05339984HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
NA · 2 location(s) · Massachusetts General Hospital · NCT05205954Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07036874TIPS With or Without BCAA
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07281846Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06153082Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial
NA · 1 location(s) · Instituto Ecuatoriano de Enfermedades Digestivas · NCT06102980Cirrhosis, Effects of TRAnsplantation and Diabetes
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT02038517ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOs
NA · 4 location(s) · University Hospital, Angers · NCT07119957
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.